Asia Pacific Genetic Toxicology Testing Market Size by 2028

Asia Pacific Genetic Toxicology Testing Market Size, Share & Industry Trends Analysis Report By Product, By Type, By Application (Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry), By Country and Growth Forecast, 2022 - 2028

Published Date: November-2022 | Number of Pages: 82 | Format: PDF | Report ID: KBV-20861

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the Asia Pacific Genetic Toxicology Testing Market

Market Report Description

The Asia Pacific Genetic Toxicology Testing Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).

Research has found that a variety of anticancer medications, including topoisomerase II inhibitors, alkylating agents, and thiopurines, can kill cancer cells and also cause sub-lethal mutations in healthy somatic cells, which may result in secondary cancers linked to the treatment. A study revealed that patients suffering from chronic lymphocytic leukemia who underwent cyclophosphamide, frontline fludarabine, and rituximab therapy had higher rates of AML and MDS and 2.38 times the risk of second malignancies compared to the general population.

Consequently, it is important to evaluate the genotoxicity of chemotherapeutic medications. There are currently many in vitro and in vivo genotoxic diagnostics, including the PIG-A assay, for tracking the genotoxicity in individuals following chemotherapy. Since it is simple to identify the mutagens in somatic cells using short-term experiments, the emphasis of genotoxicology has shifted significantly to somatic cells from germ cells and their relationship to cancer.

It was also challenging to identify human cell mutagens due to a lack of sensitive and practical innovative techniques for identifying genotoxic mutagenic consequences in germ cells. While somatic cell mutations need to accumulate over time before becoming malignant, germ cell mutations have the potential to cause a variety of disorders, prompting an increasing number of research to explore the occurrence and significance of such mutagens.

The revolution in genomics and precision medicine is well underway in the Asia Pacific region. Large worldwide collaborative efforts including the Global Alliance for Genomics and Health, International Human Epigenome Consortium, and the International Cancer Genome Consortium all involve participation from Asian nations. Using the large amounts of data that were taken from their populations, they have proactively set up public biobanks. The Hong Kong Genome Institute was formed by the Hong Kong government in 2020 to carry out large-scale genome sequencing.

The China market dominated the Asia Pacific Genetic Toxicology Testing Market by Country in 2021; thereby, achieving a market value of $192.2 million by 2028. The Japan market is registering a CAGR of 13.5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 14.9% during (2022 - 2028).

Based on Product, the market is segmented into Services, Reagents & Consumables and Assays. Based on Type, the market is segmented into In Vitro and In Vivo. Based on Application, the market is segmented into Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Genetic Toxicology Testing Market is Projected to reach USD 2.4 Billion by 2028, at a CAGR of 13.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific Group, Jubilant Pharmova Limited., Syngene International Limited, Gentronix Ltd., Inotiv Inc., Creative Bioarray and MB Research Laboratories.

Scope of the Study

Market Segments Covered in the Report:

By Product

  • Services
  • Reagents & Consumables
  • Assays

By Type

  • In Vitro
  • In Vivo

By Application

  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific Group
  • Jubilant Pharmova Limited.
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Genetic Toxicology Testing Market Report 2022-2028

North America Genetic Toxicology Testing Market Report 2022-2028

Europe Genetic Toxicology Testing Market Report 2022-2028

LAMEA Genetic Toxicology Testing Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities